January 24, 2020 | BY Mary ParkerAlso: a T-cell to target a wide variety of cancers, and a debate erupts among experts over the use of e-cigarettes
January 23, 2020 | BY Julia SchuelerWhat we learned from 190 cancer models that is helping us better target our cancer drugs
January 21, 2020 | BY Rachael KerrEnvironmental monitoring and routine testing are key tools in understanding a production site’s bioburden
January 17, 2020 | BY Mary ParkerAlso: Increasing incidence of cancer in 9/11 responders, and designing robots using frog cells
January 15, 2020 | BY Ria FalvoThe daily lessons of a toxicologist are perpetual and transferable to the next “expedition”
January 13, 2020 | BY Deborah Dormady LethamThe flu is on the rise. You can still shield yourself against circulating strains.
January 10, 2020 | BY Mary ParkerAlso: a new coronavirus could be behind Chinese outbreak, and AI motion capture for animals could have much wider impact
January 6, 2020 | BY Regina KelderHow the rare disease company TREND Community is turning virtual conversations into evidence
January 3, 2020 | BY Regina McEnery-AdminAlso: AI’s potential value in breast cancer screening, and three-year sentence for CRISPR scientist
December 23, 2019 | BY Eureka StaffFrom phage therapy and antibiotic resistance to rare diseases and drug abuse research, here are Eureka’s Top 10 Stories of the Year.
